Supporting the journey of bioengineered heart tissue
2 April 2026 From feasibility to clinical translation: supporting the journey of bioengineered heart tissue Therapeutic Innovation Australia’s (TIA) voucher program has supported early-stage work that helped enable the new spin-out, Ibnova Therapeutics, which is advancing a stem cell–based treatment for heart failure towards human clinical trials within the next three to five years. The company builds […]